Revenue of pharmaceutical bio-based products in Italy 2019-2021

Published by
Juliette Gagliardi,
Oct 24, 2023
Between 2019 and 2021, the revenue of the sector of pharmaceutical bio-based products in Italy grew. The highest value was registered in 2021, when this industry generated revenue for over 15.1 billion euros. This statistic displays the revenue of the pharmaceutical bio-based products sector in Italy from 2019 to 2021.

Revenue of the pharmaceutical bio-based products sector in Italy from 2019 to 2021 (in billion euros)

Loading statistic...

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

December 2022

Region

Italy

Survey time period

2019 to 2021

Citation formats
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$199 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Statistics on " Pharmaceutical market in Thailand "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical market in Thailand

Overview

6

Sales and production

5

Industry performance

5

Pharmaceutical licenses

5

International trade

7

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical industry in SingaporePharmaceutical industry in JapanPharmaceutical industry in ChinaPharmaceutical market in the PhilippinesPharmaceutical market in Thailand
Statista Accounts: Access All Statistics. Starting from $2,388 USD / Year
Learn more about how Statista can support your business.
Menu